The association between co-morbidities and physical performance in people with chronic obstructive pulmonary disease: A systematic review

Chronic Respiratory Disease

Volumn 11, Issue 1, 2014, Pages 3-13

  Li, Lok Sze Katrina ^a   Caughey, Gillian E ^a   Johnston, Kylie N ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

co morbidity; COPD; physical performance; systematic review

Indexed keywords

ANXIETY DISORDER; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART FAILURE; HUMAN; HYPERTENSION; METABOLIC DISORDER; OBESITY; OSTEOPOROSIS; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PULMONARY REHABILITATION; REVIEW; SYSTEMATIC REVIEW;

CO-MORBIDITY; COPD; PHYSICAL PERFORMANCE; SYSTEMATIC REVIEW;

PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; AGED; ANXIETY; COMORBIDITY; CONFIDENCE INTERVALS; DEPRESSION; EXERCISE TEST; HUMANS; MIDDLE AGED; OBESITY; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; OSTEOPOROSIS; PATIENT DROPOUTS; PHYSICAL FITNESS; SEVERITY OF ILLNESS INDEX;

EID: 84892743515     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972313516879     Document Type: Review

References (48)

1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD, http://www.goldcopd.org/uploads/users/files/GOLD-Report-2013-Feb20.pdf(2013, accessed 1 June 2013)
2. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012 ; 380: 2095-2128
3. Jones P, Brusselle G, Dal Negro R, et al. Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med. 2011 ; 105: 57-66
4. Llor C, Molina J, Naberan K, et al. Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare. Int J Clin Pract. 2008 ; 62: 585-592
5. Rabe KF, Wedzicha JA. Controversies in treatment of chronic obstructive pulmonary disease. Lancet. 2011 ; 378: 1038-1047
6. Mapel DW, Hurley JS, Frost FJ, et al. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med. 2000 ; 160: 2653-2658
7. Tkáč J, Man SFP, Sin DD. Review: systemic consequences of COPD. Ther Adv Respir Dis. 2007 ; 1: 47-59
8. O'Kelly S, Smith SM, Lane S, et al. Chronic respiratory disease and multimorbidity: prevalence and impact in a general practice setting. Respir Med. 2011 ; 105: 236-242
9. Sharafkhaneh A, Petersen NJ, Yu HJ, et al. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010 ; 5: 125-132
10. Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010 ; 65: 229-234
11. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008 ; 32: 962-969
12. Caughey GE, Roughead EE, Vitry AI, et al. Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract. 2010 ; 87: 385-393
13. Jowsey T, Jeon YH, Dugdale P, et al. Challenges for co-morbid chronic illness care and policy in Australia: a qualitative study. Aust New Zealand Health Policy. 2009 ; 6: 22-22
14. Lacasse Y, Goldstein R, Lasserson TJ, et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006 ; 4: CD003793
15. Garrod R, Marshall J, Barley E, et al. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006 ; 27: 788-794
16. Eisner MD, Blanc PD, Yelin EH, et al. COPD as a systemic disease: impact on physical functional limitations. Am J Med. 2008 ; 121: 789-796
17. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J. 2009 ; 33: 262-272
18. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009 ; 33: 1165-1185
19. Corsonello A, Incalzi RA, Pistelli R, et al. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011 ; 17: S21 - S28
20. Maltais F. Exercise and COPD: therapeutic responses, disease-related outcomes, and activity-promotion strategies. Phys Sportsmed. 2013 ; 41: 66-80
21. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007 ; 4: e296
22. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007 ; 4: e297
23. Crisafulli E, Costi S, Luppi F, et al. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax. 2008 ; 63: 487-491
24. Crisafulli E, Gorgone P, Vagaggini B, et al. Efficacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010 ; 36: 1042-1048
25. Giardino ND, Curtis JL, Andrei A, et al. Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res. 2010 ; 11: 29
26. Ramachandran K, McCusker C, Connors M, et al. The influence of obesity on pulmonary rehabilitation outcomes in patients with COPD. Chron Respir Dis. 2008 ; 5: 205-209
27. Sava F, Laviolette L, Bernard S, et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010 ; 10: 55
28. Trappenburg JC, Troosters T, Spruit MA, et al. Psychosocial conditions do not affect short-term outcome of multidisciplinary rehabilitation in chronic obstructive pulmonary disease. Arch Phys Med Rehabil. 2005 ; 86: 1788-1792
29. von Leupoldt A, Taube K, Lehmann K, et al. The impact of anxiety and depression on outcomes of pulmonary rehabilitation in patients with COPD. Chest. 2011 ; 140: 730-736
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 ; 67: 361-370
31. Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000 ; 15: 1090-1096
32. Beck AT, Steer RA Beck depression Inventory, Revised Edition (BDI). San Antonio, TX: The Psychological Corporation ; 1971 :
33. Speilberger CD Manual for the state-trait anxiety inventory. Pala Alto, CA: Consulting Psychologists Press ; 1983 :
34. Schnell K, Weiss CO, Lee T, et al. The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012 ; 12: 26
35. Herland K, Akselsen JP, Skjønsberg OH, et al. How representative are clinical study patients with asthma or COPD for a larger 'real life' population of patients with obstructive lung disease?. Respir Med. 2005 ; 99: 11-19
36. Troosters T, Weisman I, Dobbels F, et al. Assessing the impact of tiotropium on lung function and physical activity in GOLD stage II COPD patients who are naïve to maintenance respiratory therapy: a study protocol. Open Respir Med J. 2011 ; 15: 1-9
37. Holland AE, Mahal A, Hill CJ, et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease: a multi-centre randomised controlled equivalence trial. BMC Pulm Med. 2013 ; 13: 57
38. Charlson M, Pompei P, Ales K, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987 ; 40: 373-383
39. Sundararajan V, Henderson T, Perry C, et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004 ; 57: 1288-1294
40. Olomu AB, Corser WD, Stommel M, et al. Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly?. BMC Health Serv Res. 2012 ; 14: 398
41. Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Fam Pract. 2013 ; 30: 172-178
42. Sloan KL, Sales AE, Liu CF, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003 ; 41: 761-774
43. Lu CY, Barratt J, Vitry A, et al. Charlson and Rx-Risk comorbidity indices were predictive of mortality in the Australian health care setting. J Clin Epidemiol. 2011 ; 64: 223-228
44. Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008 ; 134: 43S - 56S
45. Roshanaei-Moghaddam B, Katon WJ, Russo J. The longitudinal effects of depression on physical activity. Gen Hosp Psychiatry. 2009 ; 31: 306-315
46. Thompson DR. Home-based cardiac rehab was as effective as hospital-based rehab in improving cardiac risk factors. Evid Based Nurs. 2009 ; 12: 83
47. Evans RA, Singh SJ, Collier R, et al. Generic, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure. Respir Med. 2010 ; 104: 1473-1481
48. Cote CG, Casanova C, Marin JM, et al. Validation and comparison of reference equations for the 6-min walk distance test. Eur Respir J. 2008 ; 31: 571-578